Blogs

Life Cycle of Orphan Drug Development & Commercialization Conference Set for January

October 26, 2012

Life Cycle of Orphan Drug Development & Commercialization Conference

January 16-18, 2013

Boston, MA

The Life Cycle of Orphan Drug Development & Commercialization Conference will focus on the current landscape of rare disease and orphan drug development, different forms of structural based drug designs, and specifically designed clinical trials.  Through these clinical trials, and by having connected to the right patients to participate, will increase productivity and expedite orphan drug approval and commercialization of the final product.

By attending this conference, delegates will gain a comprehensive view of the orphan drug and rare disease industry and will have a clearer understanding of the natural histories of rare diseases and how to most effectively treat them. Through maximizing translational research methods to evaluate bio-markers and surrogate markers in the patient’s body, this will assist in the design of orphan drug clinical trials resulting in quickly obtaining results and being able to send the orphan drug in for FDA approval.

 

Stay Connected

Sign up for updates straight to your inbox.

FacebookTwitterInstagramYoutube